Impact of Second-Generation PDE 5 Inhibitor, Avanafil, on Retinal Function: Studies From Ex Vivo ERG. Saeid S, Vinberg F, Koskelainen A. Invest Ophthalmol Vis Sci 2025;66:14.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saeid S, Vinberg F, Koskelainen A. Impact of Second-Generation PDE 5 Inhibitor, Avanafil, on Retinal Function: Studies From Ex Vivo ERG. Invest Ophthalmol Vis Sci 2025;66:14.
PMID: 40465265